Published in Eur Addict Res on January 01, 2005
A community-based evaluation of sudden death associated with therapeutic levels of methadone. Am J Med (2008) 2.60
The pharmacological treatment of opioid addiction--a clinical perspective. Eur J Clin Pharmacol (2010) 1.30
Syncope and QT prolongation among patients treated with methadone for heroin dependence in the city of Copenhagen. Heart (2007) 1.29
QT interval screening in methadone maintenance treatment: report of a SAMHSA expert panel. J Addict Dis (2011) 0.94
Methadone, QTc interval prolongation and torsade de pointes: Case reports offer the best understanding of this problem. Ther Adv Psychopharmacol (2013) 0.90
Retrospective analysis of low-dose methadone and QTc prolongation in chronic pain patients. Korean J Anesthesiol (2010) 0.84
Torsade de pointes caused by polypharmacy and substance abuse in a patient with human immunodeficiency virus. Int J Emerg Med (2008) 0.82
CSAT's QT interval screening in methadone report: outrageous fortune or sea of troubles? J Addict Dis (2011) 0.79
Opioid dependence and substitution therapy: thymoquinone as potential novel supplement therapy for better outcome for methadone maintenance therapy substitution therapy. Iran J Basic Med Sci (2014) 0.79
Evaluation of QTc interval in Iranian causalities (Janbazan) of Iran-Iraq war receiving maintenance methadone treatment. J Res Med Sci (2012) 0.79
A systematic review of the cardiotoxicity of methadone. EXCLI J (2015) 0.79
Levo-alpha-acetylmethadol (LAAM) induced QTc-prolongation - results from a controlled clinical trial. Eur J Med Res (2009) 0.77
Gender differences in pharmacokinetics and pharmacodynamics of methadone substitution therapy. Front Pharmacol (2015) 0.76
Relationship between methadone and EDDP (2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine) in urine samples from Norwegian prisons. Eur J Clin Pharmacol (2007) 0.76
Syncope of a drug addict - a special case. Clin Res Cardiol (2006) 0.75
Pattern of QTc prolongation in Methadone Maintenance Therapy (MMT) subjects receiving different methadone dosages: A prospective cohort study. Pak J Med Sci (2013) 0.75
Presence or Absence of QTc Prolongation in Buprenorphine-Naloxone Among Youth With Opioid Dependence. J Addict Med (2016) 0.75
The Impact of Opioids on Cardiac Electrophysiology. Curr Cardiol Rev (2016) 0.75
Effects of disulfiram on QTc interval in non-opioid-dependent and methadone-treated cocaine-dependent patients. J Addict Med (2013) 0.75
Risk-factors for methadone-specific deaths in Scotland's methadone-prescription clients between 2009 and 2013. Drug Alcohol Depend (2016) 0.75
Methadone-Associated Prolongation of the QTc Interval at Doses Used for Chronic Pain. P T (2011) 0.75
Changes of QTc interval after opioid switching to oral methadone. Support Care Cancer (2013) 0.75
Prevalence and characteristics of undiagnosed bipolar disorders in patients with a major depressive episode: the BRIDGE study. Arch Gen Psychiatry (2011) 2.10
Electroconvulsive therapy in 197 patients with a severe, drug-resistant bipolar mixed state: treatment outcome and predictors of response. J Clin Psychiatry (2015) 2.05
Dopamine agonists and delusional jealousy in Parkinson's disease: a cross-sectional prevalence study. Mov Disord (2012) 1.98
The International Society for Bipolar Disorders (ISBD) task force report on antidepressant use in bipolar disorders. Am J Psychiatry (2013) 1.97
Toward a unitary perspective on the bipolar spectrum and substance abuse: opiate addiction as a paradigm. J Affect Disord (2006) 1.69
Agitated "unipolar" depression re-conceptualized as a depressive mixed state: implications for the antidepressant-suicide controversy. J Affect Disord (2005) 1.41
Substance use and quality of life over 12 months among buprenorphine maintenance-treated and methadone maintenance-treated heroin-addicted patients. J Subst Abuse Treat (2007) 1.37
Alcohol and cocaine use and abuse among opioid addicts engaged in a methadone maintenance treatment program. J Addict Dis (2007) 1.34
Synthetic peptides in the form of dendrimers become resistant to protease activity. J Biol Chem (2003) 1.20
A systematic, updated review on the antidepressant agomelatine focusing on its melatonergic modulation. Curr Neuropharmacol (2010) 1.13
Antiepileptic drugs: indications other than epilepsy. Epileptic Disord (2004) 1.11
Obsessive-compulsive disorder and body dysmorphic disorder: a comparison of clinical features. Eur Psychiatry (2004) 1.09
Obsessive-compulsive bipolar comorbidity: focus on children and adolescents. J Affect Disord (2004) 1.08
Pharmacological response in juvenile bipolar disorder subtypes: A naturalistic retrospective examination. Psychiatry Res (2010) 0.97
Differential substance abuse patterns distribute according to gender in heroin addicts. J Psychoactive Drugs (2010) 0.96
Repeated acetyl-l-carnitine administration increases phospho-Thr34 DARPP-32 levels and antagonizes cocaine-induced increase in Cdk5 and phospho-Thr75 DARPP-32 levels in rat striatum. Eur J Neurosci (2004) 0.96
Reboxetine, a selective norepinephrine reuptake inhibitor, is an effective and well-tolerated treatment for panic disorder. J Clin Psychiatry (2002) 0.95
Attention-deficit hyperactivity disorder -- bipolar comorbidity in children and adolescents. Bipolar Disord (2006) 0.94
Identifying features of bipolarity in patients with first-episode postpartum depression: findings from the international BRIDGE study. J Affect Disord (2011) 0.94
Comparison between heroin and heroin-cocaine polyabusers: a psychopathological study. Ann N Y Acad Sci (2006) 0.92
Bipolar mixed states: an international society for bipolar disorders task force report of symptom structure, course of illness, and diagnosis. Am J Psychiatry (2013) 0.91
Clinical implications of DSM-IV subtyping of bipolar disorders in referred children and adolescents. J Am Acad Child Adolesc Psychiatry (2007) 0.90
The clinical phenotypes of juvenile bipolar disorder: toward a validation of the episodic-chronic-distinction. Biol Psychiatry (2006) 0.89
Developmental differences according to age at onset in juvenile bipolar disorder. J Child Adolesc Psychopharmacol (2006) 0.88
Affective temperaments and hopelessness as predictors of health and social functioning in mood disorder patients: a prospective follow-up study. J Affect Disord (2013) 0.88
Cyclothymic-depressive-anxious temperament pattern is related to suicide risk in 346 patients with major mood disorders. J Affect Disord (2011) 0.88
Are "social drugs" (tobacco, coffee and chocolate) related to the bipolar spectrum? J Affect Disord (2011) 0.87
Temperaments mediate suicide risk and psychopathology among patients with bipolar disorders. Compr Psychiatry (2011) 0.87
Are atypical depression, borderline personality disorder and bipolar II disorder overlapping manifestations of a common cyclothymic diathesis? World Psychiatry (2011) 0.87
Predictors of treatment nonresponse in bipolar children and adolescents with manic or mixed episodes. J Child Adolesc Psychopharmacol (2004) 0.86
QTc interval screening for cardiac risk in methadone treatment of opioid dependence. Cochrane Database Syst Rev (2013) 0.86
Affective temperaments in heroin addiction. J Affect Disord (2009) 0.86
Externalizing disorders in consecutively referred children and adolescents with bipolar disorder. Compr Psychiatry (2003) 0.86
Effect of psychiatric severity on the outcome of methadone maintenance treatment. Eur Addict Res (2010) 0.85
Cocaine abuse and the bipolar spectrum in 1090 heroin addicts: clinical observations and a proposed pathophysiologic model. J Affect Disord (2007) 0.85
Clinical and research implications of panic-bipolar comorbidity in children and adolescents. Psychiatry Res (2007) 0.85
Temperament in adolescents with anxiety and depressive disorders and in their families. Child Psychiatry Hum Dev (2003) 0.85
Behavioral expression of cocaine sensitization in rats is accompanied by a distinct pattern of modifications in the PKA/DARPP-32 signaling pathway. J Neurochem (2007) 0.84
Pediatric social anxiety disorder: predictors of response to pharmacological treatment. J Child Adolesc Psychopharmacol (2012) 0.84
Increase in IL-6 levels among major depressive disorder patients after a 6-week treatment with duloxetine 60 mg/day: a preliminary observation. Neuropsychiatr Dis Treat (2011) 0.84
The clinical-familial correlates and naturalistic outcome of panic-disorder-agoraphobia with and without lifetime bipolar II comorbidity. Ann Gen Psychiatry (2008) 0.84
Combination of aripiprazole with mood stabilizers for the treatment of bipolar disorder: from acute mania to long-term maintenance. Expert Opin Pharmacother (2012) 0.84
Negative dimension in psychiatry. Amotivational syndrome as a paradigm of negative symptoms in substance abuse. Riv Psichiatr (2013) 0.83
The mesolimbic dopaminergic response to novel palatable food consumption increases dopamine-D1 receptor-mediated signalling with complex modifications of the DARPP-32 phosphorylation pattern. J Neurochem (2005) 0.83
Long-term outcomes of treatment-resistant heroin addicts with and without DSM-IV axis I psychiatric comorbidity (dual diagnosis). Eur Addict Res (2008) 0.83
Cost-effectiveness of asenapine in the treatment of patients with bipolar I disorder with mixed episodes in an Italian context. Adv Ther (2014) 0.82
Abnormal temperament in patients with morbid obesity seeking surgical treatment. J Affect Disord (2009) 0.82
Bipolar II and anxious reactive "comorbidity": toward better phenotypic characterization suitable for genotyping. J Affect Disord (2006) 0.82
The mental status of 1090 heroin addicts at entry into treatment: should depression be considered a 'dual diagnosis'? Ann Gen Psychiatry (2007) 0.82
Sardinian alcohol-preferring rats show low 5-HT extraneuronal levels in the mPFC and no habituation in monoaminergic response to repeated ethanol consumption in the NAcS. Brain Res (2004) 0.82
Adult separation anxiety in patients with complicated grief versus healthy control subjects: relationships with lifetime depressive and hypomanic symptoms. Ann Gen Psychiatry (2011) 0.82
Aripiprazole in acute mania and long-term treatment of bipolar disorder: a critical review by an Italian working group. Clin Drug Investig (2010) 0.82
A naturalistic exploratory study of the impact of demographic, phenotypic and comorbid features in pediatric obsessive-compulsive disorder. Psychopathology (2010) 0.81
Do methadone and buprenorphine have the same impact on psychopathological symptoms of heroin addicts? Ann Gen Psychiatry (2011) 0.81
Correlations between awareness of illness (insight) and history of addiction in heroin-addicted patients. Front Psychiatry (2012) 0.81
Long-term naturalistic follow-up of patients with bipolar depression and mixed state treated with electroconvulsive therapy. J ECT (2013) 0.81
A case of deep venous thrombosis following protracted catatonic immobility recovered with electroconvulsive therapy: the relevance for an early intervention. Gen Hosp Psychiatry (2011) 0.81
The mood-stabilizing effects of electroconvulsive therapy. J ECT (2014) 0.81
Pharmacotherapy in paediatric obsessive-compulsive disorder: a naturalistic, retrospective study. CNS Drugs (2009) 0.81
Lifetime mood symptoms and adult separation anxiety in patients with complicated grief and/or post-traumatic stress disorder: a preliminary report. Psychiatry Res (2012) 0.80
Psychiatrists' perceptions of potential reasons for non- and partial adherence to medication: results of a survey in bipolar disorder from eight European countries. J Affect Disord (2012) 0.80
Bipolar co-morbidity in pediatric obsessive-compulsive disorder: clinical and treatment implications. J Child Adolesc Psychopharmacol (2007) 0.80
Modifications in DARPP-32 phosphorylation pattern after repeated palatable food consumption undergo rapid habituation in the nucleus accumbens shell of non-food-deprived rats. J Neurochem (2009) 0.80
Affective temperament traits measured by TEMPS-I and emotional-behavioral problems in clinically-well children, adolescents, and young adults. J Affect Disord (2005) 0.80
Is the bipolar spectrum the psychopathological substrate of suicidality in heroin addicts? Psychopathology (2007) 0.80
Transcultural validity of the Hypomania Checklist-32 (HCL-32) in patients with major depressive episodes. Bipolar Disord (2013) 0.79
Could the underestimation of bipolarity obstruct the search for novel antidepressant drugs? Expert Opin Pharmacother (2011) 0.79
TEMPS-A[p] temperament profile related to professional choice: A study in 1548 applicants to become a cadet officer in the Italian air force. J Affect Disord (2010) 0.78
Clonazepam as agonist substitution treatment for benzodiazepine dependence: a case report. Case Rep Psychiatry (2013) 0.78
Effects of long-term acetyl-L-carnitine administration in rats: I. increased dopamine output in mesocorticolimbic areas and protection toward acute stress exposure. Neuropsychopharmacology (2002) 0.78
Treatment adherence towards prescribed medications in bipolar-II acute depressed patients: relationship with cyclothymic temperament and "therapeutic sensation seeking" in response towards subjective intolerance to pain. J Affect Disord (2013) 0.78
Developmental pathways for different subtypes of early-onset bipolarity in youths. J Clin Psychiatry (2012) 0.78
Diagnostic and symptomatological features in chronic psychotic patients according to cannabis use status. J Psychoactive Drugs (2004) 0.78
Comparative response to electroconvulsive therapy in medication-resistant bipolar I patients with depression and mixed state. J ECT (2010) 0.78
The long-term outcomes of heroin dependent-treatment-resistant patients with bipolar 1 comorbidity after admission to enhanced methadone maintenance. J Affect Disord (2013) 0.77
Anticonvulsants for alcohol dependence. Cochrane Database Syst Rev (2014) 0.77
Study of mirtazapine antidepressant effects in rats. Int J Neuropsychopharmacol (2005) 0.77
Effects of long-term acetyl-L-carnitine administration in rats--II: Protection against the disrupting effect of stress on the acquisition of appetitive behavior. Neuropsychopharmacology (2002) 0.77
Spirituality and religiosity in the aftermath of a natural catastrophe in Italy. J Relig Health (2013) 0.77
Prevalence and diagnostic distribution of medically unexplained painful somatic symptoms across 571 major depressed outpatients. Neuropsychiatr Dis Treat (2011) 0.77
Long-term γ-hydroxybutyric acid (GHB) and disulfiram combination therapy in GHB treatment-resistant chronic alcoholics. Int J Environ Res Public Health (2011) 0.77
Use of street methadone in italian heroin addicts presenting for opioid agonist treatment. J Addict Dis (2009) 0.77
Electroretinographic assessment in major depressed patients receiving duloxetine: might differences between responders and non-responders indicate a differential biological background? J Affect Disord (2011) 0.77
[Psycho(patho)logy of "addiction." Interpretative hypothesis]. Ann Ist Super Sanita (2002) 0.76